Search Results

Phoenix Children’s, one of the nation’s fastest-growing pediatric health systems, announced today that Jared Muenzer, MD, MBA, Chief Physician Executive of the system and Chief Operating Officer for Phoenix Children’s Medical Group, was named one of Modern Healthcare’s 50 Most Influential Clinical Executives for 2024. This prestigious program honors licensed clinicians in executive roles who are paving the way to better health through their executive responsibility, leadership qualities, innovation, community service and achievements inside and outside of their respective organizations.

Angel Torres was running out of options. After multiple rounds of chemotherapy and a fruitless search for a bone marrow donor, the 3-year-old’s odds against acute lymphoblastic leukemia were grim. That changed in June, when Phoenix Children’s providers recommended CAR-T cellular therapy, a breakthrough new treatment that uses a patient’s own T-cells to attack and destroy cancer cells. Only available at a handful of children’s cancer centers nationwide, CAR-T worked for Angel, destroying the leukemia cells and giving him a second chance at life.

The Phoenix Tourette Syndrome program is a unique partnership between Phoenix Children’s and Banner Sun Health Research Institute. It first earned its Tourette Association of America (TAA) center of excellence designation in 2020.

Phoenix Children’s is pleased to announce Jared Muenzer, MD, MBA, has been promoted to serve the organization as Physician-in-Chief. As Physician-in-Chief, Dr. Muenzer will lead the nationally ranked clinical enterprise at Phoenix Children’s alongside Surgeon-in-Chief, Daniel Ostlie, MD.